MSc Banking and Finance, Universität Zürich (laufend)
BA Banking and Finance, Universität Zürich
Studien:
Serra-Burriel M, Perényi G, Laube Y, Mitchell AP, Vokinger KN. The cancer premium - explaining differences in prices for cancer vs. non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study. eClinicalMedicine 2023. DOI: https://doi.org/10.1016/j.eclinm.2023.10287. Link
Carl DL, Laube Y, Serra-Burriel M, Naci H, Ludwig WD, Vokinger KN. Comparison of uptake and prices of biosimilars in the US, Germany and Switzerland. JAMA Open 2022:5(12):e2244670. Link
Vokinger KN, Hwang TJ, Carl DL, Laube Y, Ludwig W-D, Naci H, Kesselheim AS. Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Oncology 2022. DOI: https://doi.org/10.1016/S1470-2045(22)00073-0. Link
